Insugen 50/50 Refil ?
Product Description
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
Categories
Specifications
Biocon Limited
-
IN
-
2015On CPHI since
-
2Certificates
-
5000+Employees
Company types
Primary activities
More Products from Biocon Limited (99)
-
Product GABIL?
Biocon offers a wide range of metabolic which includes gabil. Composition: gabapentin 300mg + methylcobalamin 500mcg tablets. Mechanism of action: gabapentin: action is potentially via binding to the alpha 2 delta sub units of voltage gated calcium channels and inhibition of glutamide release presynaptical... -
Product Genxtor?
Biocon offers a wide range of oncotherapeutic which includes genxtor?temsirolimus, an inhibitor of mtor, is an antineoplastic agent. Temsirolimus is a prescription medicine used to treat people with advanced kidney cancer (renal cell carcinoma or rcc) who have at least three of six prognostic risk factors.... -
Product GMAB? Plus
Biocon offers a wide range of metabolic which includes gmab plus. Composition: gla 100mg + methylcobalamin 1500mcg + ala 100mg + benfothiamine 100mg + elemental zinc 15mg - hard gelatin capsules. Mechanism of action: it is a multivitamin with mineral which acts as a secondary preventive agent and has a mul... -
Product HEPDOZE? 300mg TABS
Biocon offers a wide range of comprehensive care which includes hepdoze 300mg tabs. Composition: each film coated tablet contains: tenofovir disoproxil fumarate ip 300mg. Mechanism of action: tenofovir disoproxil (prodrug) is hydrolysed rapidly to tenofovir, subsequently phosphorylated by cellular kinases ... -
Product IMICELUM?
Biocon offers a wide range of comprehensive care which includes imicelum. Composition: each vial contains imipenem ip eq. To anhydrous imipenem - 500 mg, cilastatin sodium usp eq. To cilastatin - 500 mg, sodium bicarbonate ip added as buffer. Mechanism of action: the bactericidal activity of imipenem is fr... -
Product Insugen 30/70 Refil ?
Biocon offers a wide range of metabolic which includes insugen 30/70 refil ?. Composition: insulin biphasic, 30% soluble and 70% nph ? 3 ml cartridge of 100 iu/ml strength. In-use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn... -
Product Insugen N Refil ?
Biocon offers a wide range of metabolic which includes insugen n refil ?. Composition: isophane insulin (nph) ? 3 ml cartridge of 100 iu/ml strength. In use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the fo... -
Product Insugen R Refil ?
Biocon offers a wide range of metabolic which includes insugen r refil ?. Composition: soluble/regular insulin ? 3 ml cartridge of 100 iu/ml strength. In use stability: 42 days/6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the f... -
Product INSUGEN? 30/70
Biocon offers a wide range of metabolic which includes insugen 30/70. Composition: insulin biphasic, 30% soluble and 70% nph - 10ml vials of 100 iu/ml strength. In use stability ? 42 days / 6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is util... -
Product INSUGEN? 50/50
Biocon offers a wide range of metabolic which includes insugen 50/50. Composition: 50% soluble and 50% nph - 10ml vials of 100 iu/ml strength. In use stability ? 42 days / 6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the form o... -
Product INSUGEN? N
Biocon offers a wide range of metabolic which includes insugen n. Composition: isophane (nph) insulin - 10ml vials of 100 iu/ml strength, in use stability ? 42 days / 6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the form of ene... -
Product INSUGEN? R
Biocon offers a wide range of metabolic which includes insugen r. Composition: soluble/regular insulin - 10ml vials of 100 iu/ml strength. In use stability ? 42 days / 6 weeks. Mechanism of action: insulin opens the cell receptors for glucose molecules to enter, which in turn, is utilized in the form of en...
Biocon Limited resources (1)
-
News Viatris and Biocon score historic first for interchangeable biosimilar product
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance